Skip to main content

High-Tech Gründerfonds (HTGF) provides seed funding for the neuro start-up

FundaMental Pharma GmbH (FMP), a spin-off of the Interdisciplinary Center for Neuroscience (IZN) at Heidelberg University. FMP scientists have discovered a “death complex” in neurons whose activation leads to neurodegeneration.

With the identification of a novel class of drugs, the FMP has also laid the foundation for successfully combating life-threatening neurological diseases. The financing makes it now possible to prepare for clinical studies.

Read Article